Teens and Young Adults are Less Likely to Stick to Follow-up Guidelines After Cancer Treatment
source: pixabay.com

Teens and Young Adults are Less Likely to Stick to Follow-up Guidelines After Cancer Treatment

According to a story from The European Society For Medical Oncology, a recent study shows that young adults and teenagers are less likely to adhere to follow-up guidelines following treatment…

Continue Reading Teens and Young Adults are Less Likely to Stick to Follow-up Guidelines After Cancer Treatment
#PutPatientsFirst : The Trump Administration Wants to Allow Medical Personnel to Withhold Service Based on “Religious” Beliefs
source: pixabay.com

#PutPatientsFirst : The Trump Administration Wants to Allow Medical Personnel to Withhold Service Based on “Religious” Beliefs

According to a story from guttmacher.org, the U.S. Department of Health and Human Services proposed a host of new regulations purported to enforce over 20 federal provisions related to "conscience…

Continue Reading #PutPatientsFirst : The Trump Administration Wants to Allow Medical Personnel to Withhold Service Based on “Religious” Beliefs
These Drug Companies Are Trying to Make Treatment for Familial Hypercholestrolemia More Affordable
source: pixabay.com

These Drug Companies Are Trying to Make Treatment for Familial Hypercholestrolemia More Affordable

According to a story from PR Newswire, the pharmaceutical companies Sanofi and and Regeneron Pharmaceuticals are implementing a plan to make Praluent injections more accessible and affordable for patients with…

Continue Reading These Drug Companies Are Trying to Make Treatment for Familial Hypercholestrolemia More Affordable
Understanding The Mechanisms of Charcot-Marie-Tooth Disease Can Help Develop Treatments
jarmoluk / Pixabay

Understanding The Mechanisms of Charcot-Marie-Tooth Disease Can Help Develop Treatments

According to a story from news-medical.net, researchers from The Scripps Research Institute have successfully outlined a new path for the treatment of Charcot-Marie-Tooth disease subtype 2D (CMT2D). The scientists hope…

Continue Reading Understanding The Mechanisms of Charcot-Marie-Tooth Disease Can Help Develop Treatments
A Treatment for Batten Disease Was Given Rare Pediatric Disease Designation from the FDA
source: pixabay.com

A Treatment for Batten Disease Was Given Rare Pediatric Disease Designation from the FDA

According to a story from pharmpro.com, the pharmaceutical company Abeona Therapeutics announced that it has been given Rare Pediatric Disease Designation for its ABO-202 program by the U.S. Food and…

Continue Reading A Treatment for Batten Disease Was Given Rare Pediatric Disease Designation from the FDA
The FDA Gave Orphan Drug Designation to an Investigational Treatment For Cystic Fibrosis
Source: Pixabay

The FDA Gave Orphan Drug Designation to an Investigational Treatment For Cystic Fibrosis

According to a story from Financial Buzz, the pharmaceutical company Proteostasis Therapeutics recently announced that the company's experimental treatment PTI-428 was granted Orphan Drug Designation by the FDA. PTI-428 is…

Continue Reading The FDA Gave Orphan Drug Designation to an Investigational Treatment For Cystic Fibrosis
Nintedanib Gets Fast Track Designation for the Treatment of Scleroderma
source: pixabay.com

Nintedanib Gets Fast Track Designation for the Treatment of Scleroderma

According to a story from BioSpace, the U.S. Food and Drug Administration has given Fast Track designation for nintedanib, which is undergoing testing for the treatment of systemic sclerosis with…

Continue Reading Nintedanib Gets Fast Track Designation for the Treatment of Scleroderma
The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy
https://pixabay.com/en/approved-pass-ok-approval-symbol-1726357/

The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy

According to a story from raredr.com, The U.S. Food and Drug Administration (FDA) has recently approved Hizentra as a maintenance therapy for patients with chronic inflammatory demyelinating polyneuropathy. Hizentra is…

Continue Reading The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy
The FDA Puts a Halt to Trial for SGT-001, A Treatment in Development for Duchenne Muscular Dystrophy
source: pixabay.com

The FDA Puts a Halt to Trial for SGT-001, A Treatment in Development for Duchenne Muscular Dystrophy

According to a story from raredr.com, the FDA had to order the cessation of Phase II/III trials for the microdystrophin transfer therapy SGT-001, which was in development for the treatment…

Continue Reading The FDA Puts a Halt to Trial for SGT-001, A Treatment in Development for Duchenne Muscular Dystrophy
This Disease is Considered a “Delusion” by The Medical Community. A New Study Says It’s Not.
source: pixabay.com

This Disease is Considered a “Delusion” by The Medical Community. A New Study Says It’s Not.

According to a story from BioPortfolio, a recent study claims the Morgellons disease, a condition that has been shrouded in confusion and controversy, is not a delusion as some prior…

Continue Reading This Disease is Considered a “Delusion” by The Medical Community. A New Study Says It’s Not.
Children with Chronic Kidney Disease May Have Learning Problems Because of Dialysis
source: pixabay.com

Children with Chronic Kidney Disease May Have Learning Problems Because of Dialysis

According to a story from drugs.com, kids and teenagers with chronic kidney disease (CKD) may develop problems with learning and cognition, a new study suggests. Researchers emphasize that patients on…

Continue Reading Children with Chronic Kidney Disease May Have Learning Problems Because of Dialysis
Personal Independent Payment Assessments Are an Excuse to Strip Assistance Away From People With Disabilities
source: pixabay.com

Personal Independent Payment Assessments Are an Excuse to Strip Assistance Away From People With Disabilities

According to a story from The Independent, Britain's disability welfare program is coming under fire for its Personal Independent Payment (PIP) assessments. Statistical measures suggest that these assessments are taking…

Continue Reading Personal Independent Payment Assessments Are an Excuse to Strip Assistance Away From People With Disabilities
The FDA is Beginning to Accept New Endpoints and “Real World” Data in Clinical Trials
vitalworks / Pixabay

The FDA is Beginning to Accept New Endpoints and “Real World” Data in Clinical Trials

According to a story from Charcot-Marie-Tooth Disease News, the U.S. Food and Drug Administration (FDA), under the leadership of commissioner Scott Gottlieb, has begun to change clinical trials by accepting…

Continue Reading The FDA is Beginning to Accept New Endpoints and “Real World” Data in Clinical Trials
This Cancer Drug May Reduce Hearing Loss From Radiotherapy In Patients With Neurofibromatosis
RobinHiggins / Pixabay

This Cancer Drug May Reduce Hearing Loss From Radiotherapy In Patients With Neurofibromatosis

According to a story from Medical Xpress, the addition of crizotinib with radiation therapy could help reduce hearing loss associated with the treatment in patients with neurofibromatosis II. Crizotinib is…

Continue Reading This Cancer Drug May Reduce Hearing Loss From Radiotherapy In Patients With Neurofibromatosis